Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding

Cited by (589)

Items 401–500 of 589

  1. Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism
    Ashley Patton, Farooq H. Khan, Rohit Kohli · 2017 · Digestive Diseases
  2. Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling
    Sobuj Mia, Georgios Siokatas, Rafailia Sidiropoulou, Matthew Hoffman, Konstantinos Fragkiadakis, Eftychia Markopoulou, Mahmoud Elesawy, Rajika Roy, Scott Blair, Yasuhide Kuwabara et al. · 2025 · Cell Reports Medicine
  3. Brain-acting hepatokines: its impact on energy balance and metabolism
    Lucía Giovanini, Nahuel Ezequiel Wanionok, Mario Perelló, María Paula Cornejo · 2025 · Frontiers in Neuroscience
  4. Sex modulates the association of fibroblast growth factor 21 with end‐stage renal disease in Asian people with Type 2 diabetes: a 6.3‐year prospective cohort study
    Jianjun Liu, Si Liu, Robin Wai Munn Choo, Shiou Liang Wee, A Xu, Su Chi Lim · 2018 · Diabetic Medicine
  5. Sesamol promotes browning of white adipocytes through liver-adipose crosstalk signal of hepatic fibroblast growth factor 21.
    Ming-Hui Cheng, Wenya Zheng, Quan Zhang, Zhu Liu, Jing-Fang Chen, Mahnoor Atta, Hong Qin · 2023 · Journal of Nutritional Biochemistry
  6. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
    Lucas Zangerolamo, Marina Uchôa Wall Barbosa De Carvalho, Licio Augusto Velloso, Helena C.L. Barbosa · 2023 · European Journal of Pharmacology
  7. Pharmacologic stimulation of central GLP-1 receptors has opposite effects on the alterations of plasma FGF21 levels induced by feeding and fasting
    Katsunori Nonogaki, Takao Kaji, Tomoe Yamazaki, Mari Murakami · 2015 · Neuroscience Letters
  8. Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
    Panos G. Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana E. Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia E Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G. Habeos · 2016 · PLoS ONE
  9. Green tea improves the metabolism of peripheral tissues in β3-adrenergic receptor-knockout mice
    Celso Pereira Batista Sousa Filho, Hector Oreliana Fernandes Faria, Juliana Carvalho Esposito, Alessandra Melo, Miriam Oliveira Ribeiro, Rosemari Otton · 2020 · Pharmacological Research
  10. A Small Molecule, UAB126, Reverses Diet-Induced Obesity and its Associated Metabolic Disorders
    Guang Ren, Teayoun Kim, Hae-Suk Kim, Martin Elliot Young, Donald D. Muccio, Venkatram R. Atigadda, Samuel I. Blum, Hubert Ming Tse, Kirk M. Habegger, Sushant Bhatnagar et al. · 2020 · Diabetes
  11. NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice
    Fangfei Guo, Marcus Michael Seldin, Miklós Péterfy, Sarada Charugundla, Zhiqiang Zhou, Stephen D. Lee, Alice Mouton, Prashant Rajbhandari, Wenchao Zhang, Matteo A. Pellegrini et al. · 2021 · Scientific Reports
  12. Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle
    Jun Peng, Liming Yu, Linzhang Huang, Vivian A. Paschoal, Haiyan Chu, Camila Oliveira de Souza, Joseph Vinod Varre, Da Young Oh, Jennifer J. Kohler, Xue Xiao et al. · 2023 · Molecular Metabolism
  13. Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog
    Kristian Sass‐Ørum, Tina M. Tagmose, Jørgen Olsen, Annika Sjölander, Per‐Olof Wahlund, Dan Han, Andreas Vegge, Steffen Reedtz‐Runge, Zhe Wang, Xiang Gao et al. · 2024 · Journal of Medicinal Chemistry
  14. Circulating Fibroblast Growth Factor-21 in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Ioanna Filimidou, Myrsini Orfanidou, Antonis Goulas, Όλγα Γιουλεμέ, Stergios A. Pοlyzos · 2025 · Current Obesity Reports
  15. Uncoupling Protein-1 Modulates Anxiety-Like Behavior in a Temperature-Dependent Manner
    Spyridon Sideromenos, Anna Gundacker, Maria Nikou, Raimund Oberle, Orsolya Horváth, Peter Stöhrmann, Timo Partonen, Daniela D. Pollak · 2022 · Journal of Neuroscience
  16. Pharmacological effects of fibroblast growth factor 21 are sex-specific in mice with the lethal yellow (Ay) mutation
    Makarova En, T. V. Yakovleva, Natalia Balybina, Konstantin O. Baranov, E. I. Denisova, Anastasia Dubinina, Natalia A. Feofanova, Н. М. Бажан · 2020 · Vavilov Journal of Genetics and Breeding
  17. Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice
    Brenna R. Kaelin, Collin M. McKenzie, Karl W. Hempel, Anna L. Lang, Gavin E. Arteel, Juliane I. Beier · 2020 · Toxicology and Applied Pharmacology
  18. Psychology and Pathophysiological Outcomes of Eating
    Akikazu Takada, Hubertus Himmerich · 2021 · IntechOpen eBooks
  19. SNAI1 is upregulated during muscle regeneration and represses FGF21 and ATF3 expression by directly binding their promoters
    Ines Elia, Giulia Realini, Vittoria Di Mauro, Sara Borghi, Laura Bottoni, Salvatore Tornambè, Libero Vitiello, Stephen J. Weiss, Mario Chiariello, Annalaura Tamburrini et al. · 2022 · The FASEB Journal
  20. Circulating fibroblast growth factor 21 is reduced, whereas its production is increased in a fat depot-specific manner in cold-acclimated rats
    Diane M. Sepa-Kishi, Rolando Bacis Ceddia · 2018 · Adipocyte
  21. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids
    Marta Correia de Sousa, Etienne Delangre, Flavien Berthou, Sanae El Harane, Christine Maeder, Margot Fournier, Karl‐Heinz Krause, Monika Gjorgjieva, Michelangelo Foti · 2024 · JHEP Reports
  22. Exerkines: Potential regulators of ferroptosis
    Min Jia, Fengxing Li, Tong Wu, Ning Chen · 2025 · Journal of sport and health science/Journal of Sport and Health Science
  23. Aerobic Exercise Activates Fibroblast Growth Factor 21 and Alleviates Cardiac Ischemia/Reperfusion-induced Neuronal Oxidative Stress and Ferroptosis in Paraventricular Nucleus
    Yifang Zhao, Lili Feng, Chenyang Wu, Yuxiang Xu, Wenyan Bo, Lingyun Di, Shou Pan, Mengxin Cai, Zhenjun Tian · 2025 · Molecular Neurobiology
  24. Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du · 2025 · Frontiers in Endocrinology
  25. Wogonin, a Compound in Scutellaria baicalensis, Activates ATF4–FGF21 Signaling in Mouse Hepatocyte AML12 Cells
    Yasunari Yamada, Hodaka Saito, Masaya Araki, Yuhei Tsuchimoto, Shin-ichi Muroi, Suzuki Kyohei, Kazufumi Toume, Jun‐Dal Kim, Takashi Matsuzaka, Hirohito Sone et al. · 2022 · Nutrients
  26. Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy
    Zhensheng Zhang, Xu Li, Xun Qiu, Xinyu Yang, Zhengxing Lian, Xuyong Wei, Di Lu, Xiao Xu · 2023 · Journal of Zhejiang University SCIENCE B
  27. Starvation‐induced transcription factor CREBH negatively governs body growth by controlling GH signaling
    Yoshimi Nakagawa, Kae Kumagai, Song‐iee Han, Yuhei Mizunoe, Masaya Araki, Seiya Mizuno, Hiroshi Ohno, Kazuya Matsuo, Yasunari Yamada, Jun‐Dal Kim et al. · 2021 · The FASEB Journal
  28. Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans
    Thomas P. J. Solomon, Steven Carter, Jacob M. Haus, Kristian Karstoft, Stephanie von Holstein‐Rathlou, Mette S. Nielsen, Matthew Paul Gillum · 2022 · PeerJ
  29. Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next
    Tianru Jin · 2022 · Medical Review
  30. Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
    Martin Franck, Katharina John, Sherin Al Aoua, Monika Rau, Andreas Geier, Jörn Markus Schattenberg, Heiner H. Wedemeyer, Klaus Schulze‐Osthoff, Heike Bantel · 2023 · Liver International
  31. Design of a Dual Agonist of Exendin-4 and FGF21 as a Potential Treatment for Type 2 Diabetes Mellitus and Obesity
    Changzhen Zhang, Guosheng Gao, Yafeng Li, Jingjing Ying, Jianhui Li, Supei Hu · 2023 · Iranian journal of pharmaceutical research
  32. A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction‐associated steatotic liver disease
    Shifang Tang, Jürgen T. Borlak · 2025 · Clinical and Translational Medicine
  33. Identification and expression patterns of adipokine genes during adipocyte differentiation in the Tibetan goat ( Capra hircus )
    Xueying Li, Yan Wang, Jiazhong Guo, Tao Zhong, Li Li, Hongping Zhang, Linjie Wang · 2017 · Gene
  34. 4-Phenylbutyric acid improves free fatty acid-induced hepatic insulin resistance in vivo
    Sandra Pereira, Jessy Moore, Jia-Xu Li, Wen Yu, Husam Ghanim, Filip Vlavcheski, Yemisi Deborah Joseph, Paresh Dandona, Allen Volchuk, Carolyn L. Cummins et al. · 2021 · Endocrine Connections
  35. Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice
    Jaimarie Sostre‐Colón, Matthew J. Gavin, Dominic Santoleri, Paul M. Titchenell · 2022 · Endocrinology
  36. Effects of quercetin on hepatic fibroblast growth factor-21 (FGF-21) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) levels in rats fed with high fructose
    Kardelen Kocaman Kalkan, Serkan Şen, Belkıs Narlı, Cemile Merve Seymen, Canan Yılmaz · 2023 · Molecular Biology Reports
  37. The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
    Michael M. Richter, Peter Plomgaard · 2021 · Journal of the Endocrine Society
  38. Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice
    Jia Nuo Feng, Weijuan Shao, Lin Yang, Juan Pang, Wenhua Ling, Dinghui Liu, Michael B. Wheeler, Housheng Hansen He, Tianru Jin · 2025 · Nutrition and Diabetes
  39. Liver-Specific Nonviral Gene Delivery of Fibroblast Growth Factor 21 Protein Expression in Mice Regulates Body Mass and White/Brown Fat Respiration
    Nathaniel G. Girer, Victoria G. Rontoyanni, Aditya Joshi, Igor Patrikeev, Andrew J. Murton, Craig C. Porter, Massoud Motamedi, Cornelis J. Elferink · 2021 · Journal of Pharmacology and Experimental Therapeutics
  40. Metabogenomic analysis to functionally annotate the regulatory role of long non-coding RNAs in the liver of cows with different nutrient partitioning phenotype
    Wietje Nolte, Rosemarie Weikard, Elke Albrecht, Harald Michael Hammon, Christa Kühn · 2021 · Genomics
  41. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha‐Xiang Guan, Jia‐Hao Tao, Yong Zhou · 2022 · Oxidative Medicine and Cellular Longevity
  42. Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression
    Kyeong‐Min Lee, Yeo Jin Hwang, Gwon‐Soo Jung · 2022 · Biochemical and Biophysical Research Communications
  43. Chloroquine attenuates diet-induced obesity and glucose intolerance through a mechanism that might involve FGF-21, but not UCP-1-mediated thermogenesis and inhibition of adipocyte autophagy
    Milene Ortiz‐Silva, Bianca Franco Leonardi, Érique Castro, Álbert S. Peixoto, Gustavo R. Gilio, Tiago E. Oliveira, Caroline Aparecida Tomazelli, Maynara Lucca Andrade, Mayara Franzoi Moreno, Thiago Belchior et al. · 2023 · Molecular and Cellular Endocrinology
  44. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
    Erli Pei, Yang Liu, Weiqing Jiang, Songruo Lin, Lei Huang, Moubin Lin, Li Cai · 2018 · Lipids in Health and Disease
  45. Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications
    Siddharth pravin Agrawal, Lana Tannous, Ritu Chandra Prakash Tated, Darshilkumar Maheta, Jaishkar Ramesh, Hritvik Jain, William H. Frishma, Wilbert S. Aronow · 2025 · Cardiology in Review
  46. Inter-Organ Communication Involved in Brown Adipose Tissue Thermogenesis
    Kei Takahashi, Tetsuya Yamada, Hideki Katagiri · 2024 · Advances in experimental medicine and biology
  47. Acute retinol mobilization by retinol-binding protein 4 in mouse liver induces fibroblast growth factor 21 expression
    Julia S. Steinhoff, Carina Wagner, Ulrike Taschler, Sascha Wulff, Marie F. Kiefer, Konstantin M. Petricek, Sylvia J. Wowro, Moritz Oster, Roberto E. Flores, Na Young Yang et al. · 2022 · Journal of Lipid Research
  48. Modulation of GCN2/eIF2α/ATF4 Pathway in the Liver and Induction of FGF21 in Young Goats Fed a Protein- and/or Phosphorus-Reduced Diet
    Sarah L. Weber, Karin Hustedt, Nadine Schnepel, Christian Visscher, Alexandra S. Muscher‐Banse · 2023 · International Journal of Molecular Sciences
  49. Correlation of circulating fibroblast growth factor 21 levels with inflammatory factors and the degree of coronary artery stenosis in patients with acute myocardial infarction
    Xu Liu, Mengying Dong, Tianyi Li, Junnan Wang · 2024 · Cytokine
  50. Protein-carbohydrate interaction effects on energy balance, FGF21, IGF-1, and hypothalamic gene expression in rats
    Joséphine Gehring, Dalila Azzout‐Marniche, Catherine Chaumontet, Julien Piedcoq, Claire Gaudichon, Patrick C. Even · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  51. The role of FGF21 in the metabolic adjustments required for exercise capacity
    Abe, Lisa, Dantzer, Robert · 2025 · Life Sciences
  52. Adipocyte FGF21 Signaling Defect Aggravated Adipose Tissue Inflammation in Gestational Diabetes Mellitus
    Lun Hua, Yi Yang, Haoqi Zhang, Xuemei Jiang, Chao Jin, Bin Feng, Lianqiang Che, Shengyu Xu, Yan Lin, De Wu et al. · 2024 · Nutrients
  53. D-allulose enhances lipid oxidation in HepG2 cells via peroxisome proliferator-activated receptor α (PPARα)
    Firas Warda, Jennifer Batch, Lauren Graham, Michael John Haas, Arshag D. Mooradian · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  54. Time-restricted feeding mitigates HFD-induced sarcopenic obesity in aging mice through improving the sensitivity of FGF21
    Ting Wang, Hongkun Lin, Yan Deng, Wenwen Chen, Yangliu Xu, Li Wang, Ao-jia Zhou, Yidan Zhang, Ziping Wang, Xin Jin et al. · 2025 · The Journal of Nutritional Biochemistry
  55. Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
    Davide Misceo, Gabriele Mocciaro, Simona D’Amore, Michèle Vacca · 2024 · Nutrition & Metabolism
  56. Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults
    Hae Jin Lee, Jinyoung Shon, Yoon Jung Park · 2023 · Nutrients
  57. Hyperphagia of female UCP1-deficient mice blunts anti-obesity effects of FGF21
    Marlou Klein Hazebroek, Rutger Laterveer, Maria Kutschke, Vida Ramšak Marčeta, Clarissa Souza Barthem, Susanne Keipert · 2023 · Scientific Reports
  58. Improved leptin sensitivity and increased soluble leptin receptor concentrations may underlie the additive effects of combining PYY(3–36) and exendin-4 on body weight lowering in diet-induced obese mice
    Birgitte Schjellerup Wulff, Rune E. Kuhre, Madhan Selvaraj, Jens Frederik Rehfeld, Kristoffer Niss, Johannes Josef Fels, Anna Secher, Kirsten Raun, Marina Kjærgaard Gerstenberg · 2024 · Heliyon
  59. Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKAy mice
    Katsunori Nonogaki, Takao Kaji, T Yamazaki, Mari Murakami · 2016 · Nutrition and Diabetes
  60. Adipose expression of CREB3L3 modulates body weight during obesity
    Maximilian A. McCann, Yanliang Li, Marcos David Munoz, Victoria Gil, Guifen Qiang, José Córdoba‐Chacón, Matthias Blüher, Stephen A. Duncan, Chong Wee Liew · 2021 · Scientific Reports
  61. Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes
    Rongbin Chen, Qiyu Wang, Yuan Yuan Wang, Yadi Wang, Jianghua Liu, Zhe‐Zhen Liao, Xinhua Xiao · 2023 · Frontiers in Endocrinology
  62. Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease
    Toru Ishikawa, Nanako Terai, Takanori Igarashi, Shun Yamazaki, Takamasa Kobayashi, Toshifumi Sato, Akito Iwanaga, Tomoe Sano, Junji Yokoyama, Terasu Honma · 2023 · Clinical and Experimental Hepatology
  63. The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
    Maria Moreno-Lopez, Isaline Louvet, Nathalie Delalleau, Ana Acosta-Montalvo, Julien Thévenet, Gianni Pasquetti, Valéry Gmyr, Julie A. Kerr-Conte, François N. Pattou, Caroline Bonner et al. · 2024 · Diabetes Obesity and Metabolism
  64. Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside
    Yeping Huang, Bin Liu, Cheng Hu, Yan Lu · 2025 · Protein & Cell
  65. Combined treatment with teneligliptin and canagliflozin additively suppresses high-fat diet-induced body weight gain in mice with modulation of lipid metabolism-related gene expression
    Satoko Kawarasaki, Honami Sawazaki, Hiroaki Iijima, Haruya Takahashi, Wataru Nomura, Kazuo Inoue, Teruo Kawada, Tsuyoshi Goto · 2023 · European Journal of Pharmacology
  66. Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
    Lun Hua, Wen Shen, Dengfeng Gao, Yi Yang, Xiaohan Yang, Haoqi Zhang, Siyuan Liu, Luting Liu, Yaxue Cao, Xuemei Jiang et al. · 2025 · Cell Reports
  67. Chinese medicine formulation Mailuoning attenuates high-fat diet-induced obesity by regulating thermogenesis through activating the peroxisome proliferator-activated receptor α/fibroblast growth factor 21 axis
    Wangya Jia, Sijia Wu, Keke Wang, Xiaoyi Wang, Jian Li, Hong Xu, Lili Ji · 2025 · Phytomedicine
  68. Impacts of minimally-processed omnivorous vs lacto-ovo-vegetarian diets on insulin sensitivity, lipid profile, and adiposity in older adults: Secondary findings from a randomized crossover feeding trial
    Saba Vaezi, Jessica Freeling, Bruna O de Vargas, Lee A. Weidauer, Marni E. Shoemaker, Wade M. Sanders, Moul Dey · 2025 · Clinical Nutrition
  69. Metformin Preserves Insulin Secretion in Pancreatic β-cells through FGF21/Akt Pathway In vitro and In vivo
    Jianting Li, Qiang Jiang, Xin Wang, Lulu Hou, Lulu Wang, Kai Lou, Shuguang Pang · 2023 · Combinatorial Chemistry & High Throughput Screening
  70. Association of FGF21 with Metabolic and Cardiovascular Diseases: A Mendelian Randomization Analysis
    Qingwen He, Yuguang Li, Renqiang Yu, Mengyuan Lin · 2025 · Experimental and Clinical Endocrinology & Diabetes
  71. Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptor
    Canjun Zhu, Zhiyue Xu, Yexian Yuan, Tao Wang, Chang Xu, Cong Yin, Peipei Xie, Pingwen Xu, Hui Ye, Nirali Patel et al. · 2021 · Endocrinology Diabetes & Metabolism
  72. Hormones that are involved in metabolic homeostasis: Overview of the past century and future perspectives
    Jia Nuo Feng, Tianru Jin · 2022 · Obesity Medicine
  73. Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
    Qin-Ying She, Lijuan Li, Ming-Hong Liu, Ru-Yu Tan, Yi-Wen Zhong, Jing‐Fu Bao, Jie-Dong Xie · 2022 · Frontiers in Pharmacology
  74. Hepatic Oleate Regulates Insulin-like Growth Factor-Binding Protein 1 Partially through the mTORC1-FGF21 Axis during High-Carbohydrate Feeding
    Lucas M. O’Neill, Yar Xin Phang, Zhaojin Liu, Sarah A. Lewis, Ahmed Aljohani, Ayren McGahee, Gina Wade, Mugagga Kalyesubula, Judith Simcox, James Mukasa Ntambi · 2022 · International Journal of Molecular Sciences
  75. A Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression and Circulating FGF21 in Mice Fed A High-Fat Diet
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  76. FGF-21 Conducts a Liver-Brain-Kidney Axis to Promote Renal Cell Carcinoma
    Zongyu Li, Xinyi Zhang, Wanling Zhu, Cuiling Zhang, Katherine Sadak, Alexandra A. Halberstam, Jason Robert Brown, Curtis J. Perry, Azia Bunn, David A. Braun et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  77. The Anti-Obesity Effect of Fish Oil in Diet-Induced Obese Mice Occurs via Both Decreased Food Intake and the Induction of Heat Production Genes in Brown but Not White Adipose Tissue
    Takahiko Obo, Hiroshi Hashiguchi, Eriko Matsuda, Shigeru Kawade, Kazuma Ogiso, Haruki Iwai, Koji Ataka, Osamu Yasuda, Aiko Arimura, Takahisa Deguchi et al. · 2024 · International Journal of Molecular Sciences
  78. Timing of exercise differentially impacts adipose tissue gain in male adolescent rats
    Yevheniy Kutsenko, L. Iñiguez, Alberto Barreda, Luis Pardo-Marín, Ángel Toval, Daniel Garrigos, Marta Martínez-Morga, S Pujante, Bruno Ribeiro Do Couto, K.Y. Tseng et al. · 2025 · Molecular Metabolism
  79. FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
    Ewa Szczepańska, Piotr Glinicki, Wojciech Zgliczyński, Jadwiga Slowinska-Srzednicka, Helena Jastrzębska, Małgorzata Gietka‐Czernel · 2022 · Frontiers in Endocrinology
  80. BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice
    Zara J. Franklin, Lorenzo Croce, Ruta Dekeryte, Mirela Delibegović, Bettina Platt · 2023 · Neurobiology of Disease
  81. Size matters: the biochemical logic of ligand type in endocrine crosstalk
    Jameel Barkat Lone, Jonathan Z. Long, Katrin J. Svensson · 2023 · Life Metabolism
  82. FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway
    Ruixue Li, Xi Liu · 2024 · Cell Biochemistry and Biophysics
  83. Gut microbiota and their relationship with circulating adipokines in an acute hepatic encephalopathy mouse model induced by surgical bile duct ligation
    Bokyung Lee, Danbi Jo, Jihyun Park, Oh Yoen Kim, Juhyun Song · 2024 · Heliyon
  84. Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
    Samuel Dinerman, Yan Shu · 2025 · International Journal of Translational Medicine
  85. No strong evidence of the protein leverage hypothesis in pregnant women with obesity and their infants
    Maryam Kebbe, Jasper Most, Abby D. Altazan, Leanne Maree Redman · 2023 · Obesity
  86. Therapeutic effect of long-acting FGF21 with controlled site-specific modification on nonalcoholic steatohepatitis
    Jianying Qi, Zhimou Guo, Shenglong Zhu, Xuan Jade Jiang, Yuanyuan Wu, Yingli Chen, Fei Hu, Jingjing Xiong, Yunzhou Wu, Xianlong Ye et al. · 2024 · International Journal of Biological Macromolecules
  87. Regeneration of Non-Alcoholic Fatty Liver Cells Using Chimeric FGF21/HGFR: A Novel Therapeutic Approach
    Sung-Jun Kim, So Jung Kim, Jeongeun Hyun, Hae‐Won Kim, Jun‐Hyeog Jang · 2024 · International Journal of Molecular Sciences
  88. A Tryptophan Hydroxylase Inhibitor Increases Hepatic FGF21 Production and Decreases Hepatic Gluconeogenesis Independently of Insulin in db/db Mice
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  89. Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKAy mice
    Katsunori Nonogaki, Takao Kaji · 2020 · Heliyon
  90. New Medical Treatment Strategies for Nonalcoholic Steatohepatitis
    Michael A. Fuchs · 2015 · Current Treatment Options in Gastroenterology
  91. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
    Judita Klímová, Tomáš Zelinka, Ján Rosa, Branislav Štrauch, D Haluzíková, Martin Haluzı́k, Robert Holaj, Zuzana Krátká, Jan Kvasnička, Viktorie Ďurovcová et al. · 2019 · Cancers
  92. Fibroblast Growth Factor 21 (FGF21) creates sugar-specific taste aversion to fructose through action in the brain in mice
    Darko Stevanović, Alex J. Hebert, Bhavna N. Desai, Garima Singhal, Andrew Charles Adams, Jeffrey S. Flier, Eleftheria Maratos–Flier · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Pancreatic Islets as a Target of Adipokines
    Moritz Reiterer, Ankit Gilani, James C. Lo · 2022 · Comprehensive physiology
  94. Deletion of Arntl, a component of the molecular clock, in adipocytes leads to cellular hypertrophy by increasing insulin sensitivity via FGF21
    Hirotake Ishii, Satoshi Kitaura, Taira Wada, Shigeki Shimba · 2025 · npj Biological Timing and Sleep
  95. Distinct Fgf21 Expression Patterns in Various Tissues in Response to Different Dietary Regimens Using a Reporter Mouse Model
    Xinhui Zhang, Zixuan Li, Shuying Wang, Yan Chen · 2025 · Nutrients
  96. Exercise Suppresses Appetite in Obesity: A Biochemical, Metabolic, and Molecular Approach
    Omid Razi, Nastaran Zamani, Camila de Moraes, Ismail Laher, Marios Hadjicharalambous · 2025 · Applied Sciences
  97. Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection
    Chuyan Wang, Miao Yu, Yilin Che, Ruyi Du, Yaoyao Xu, Junqi Niu, Xiumei Chi · 2025 · Frontiers in Cellular and Infection Microbiology
  98. Targeting hepatocyte-specific SLC2A8 blocks hepatic steatosis and dissociates TCA cycle flux inhibition from glutamine anaplerosis
    Joshua A. Adams, Yiming Zhang, Jiameng Sun, Andrew Tilston-Lünel, Cassandra B. Higgins, Monique R. Heitmeier, Samuel J. Ballentine, Eric Tycksen, Roland E. Dolle, Paul W. Hruz et al. · 2025 · Hepatology Communications
  99. Liver–pancreas communication in disease and drug development
    Yan Jia, Qingtian Zhu, Qiong Pan, Guotao Lu, Jia Xiao · 2026 · Acta Pharmaceutica Sinica B
  100. Receptor Tyrosine Kinases and the Insulin Signaling System
    Morris F. White · 2018 · Endocrinology